Related Experiment Videos

Occurrence and significance of riboflavin deficiency in preterm infants

A Lucas1, C J Bates

  • 1MRC Dunn Nutritional Laboratory, Cambridge, England.

Biology of the Neonate
|January 1, 1987
PubMed

Insights

Premature infants fed human milk risk riboflavin deficiency. Supplementation is recommended, but caution is advised for infants undergoing phototherapy due to potential risks.

Area of Science:

  • Neonatal Nutrition
  • Biochemistry
  • Pediatric Medicine

Background:

  • Riboflavin deficiency is understudied in premature infants.
  • Human milk can degrade riboflavin during storage and delivery.
  • Neonatal riboflavin deficiency differs metabolically from later-life deficiency.

Purpose of the Study:

  • To explore riboflavin requirements in premature infants.
  • To describe methods for assessing functional riboflavin needs non-invasively.
  • To provide guidance on riboflavin supplementation for high-risk infants.

Main Methods:

  • Non-invasive techniques for assessing functional riboflavin requirements.
  • Review of existing literature on riboflavin metabolism in neonates.
  • Analysis of risks associated with riboflavin supplementation and phototherapy.

Main Results:

  • Premature infants receiving human milk are at risk of biochemical riboflavin deficiency.
  • Animal studies indicate unique metabolic effects of riboflavin deficiency in neonates.
  • A daily intake of at least 300 micrograms of riboflavin is suggested for human milk-fed infants.

Conclusions:

  • Supplementing human milk-fed premature infants with riboflavin is prudent.
  • Potential dangers of over-supplementation exist, particularly for infants receiving phototherapy.
  • Further research is needed to establish optimal riboflavin intake levels and safety thresholds.

Related Concept Videos